Benzinga  48 min ago  Comment 
BlackBerry Limited (NASDAQ: BBRY) revealed that a federal jury ruled in favor of the Canadian firm in a patent infringement case filed by Mobile Telecommunications LLC (MTel) in the District Court for the Northern District of Texas in the United...
Wall Street Journal  8 hrs ago  Comment 
Benzinga  Jul 21  Comment 
The Spectranetics Corporation (NASDAQ: SPNC) revealed Thursday that the Court of Appeals for the Federal Circuit in the United States reversed in part, as well as affirmed in part trial court rulings in respect of patent infringement. This was...
Motley Fool  Jul 21  Comment 
The leading distributor of fitness trackers comes under fire after falling short in a legal battle and slowdown concerns arise following a pair of analyst consumer surveys.
TechCrunch  Jul 21  Comment 
 Pop quiz, hot shot: You’re a delivery drone with a flight duration of 20 minutes with your current payload, but because of delays (use your imagination) you’re never going to make it in time. What do you do, hot shot? What do you do? You...
Benzinga  Jul 20  Comment 
Snapchat published a patent last week that suggests the company may be using Augmented Reality for their advertising. Snapchat has already been one of the pioneers of the wildly popular technology with its Lens Selfie filters that augment users...
Benzinga  Jul 20  Comment 
BioTelemetry, Inc. (NASDAQ: BEAT) revealed that the District Court in the District of Massachusetts has reached Consent Judgment on July 14 permanently enjoining and restraining InfoBionic, Inc. on the patent enforcement issue. According to...
Wall Street Journal  Jul 20  Comment 
A tiny Chinese firm’s patent victory over Apple reflects Beijing’s efforts to better protect intellectual property that often work against Western firms—but sometimes benefit them.
Motley Fool  Jul 18  Comment 
The patent protection specialist expects large revenue gains, but will its bottom line benefit?
The Economic Times  Jul 17  Comment 
The decision was challenged by Traditional Knowledge Digital Library (TKDL), a wing of the Council of Scientific and Industrial Research (CSIR) under the Ministry of S&T.  Jul 14  Comment 
Senator calls for changes to Trans-Pacific Partnership, saying Australia wants biologics to come off patent too quickly A US senator claims Australia wants to steal American medicine patents under provisions in a 12-nation trade...



Patent is the right to ownership,as part of an intellectual property law, where by a person / organization discovers a lesser known concept or invents something new and holds sole intellectual ownership rights to that particular idea. These are usually published / granted after a lot of research and exhaustive verification. Patents are generally registered with United States Patent and Trademark Office, an Agency Of The United States Department Of Commerce, in the United States and The Intellectual Property Office,a division of the Department for Innovation, Universities & Skills in the United Kingdom.

Technological Patents

Pharmaceutical Patents

Pharmaceutical patents protect manufacturers of prescription drugs, prohibiting others from producing a drug during the length of its patent protection. The length of these patents varies in different countries, though they are usually between 15-20 years. In the U.S., a pharmaceutical patent is valid for 20 years. Drug companies usually apply for patent protection before they actually begin producing the drug, opting instead to secure their rights to a particular compound at the beginning of the testing process. By the time a drug comes to market, there may only be 8-10 years of patent protection remaining, which is significantly less than the 20 offered by the patent. Companies often attempt to extend these patents by making slight reformulations of the original compound or proving its effectiveness at treating a condition other than the one for which it was originally granted a patent. This is referred to as "evergreening", a practice which many criticize.

For further information on the process of obtaining pharmaceutical patents and regulatory approval, see Clinical Trials and FDA Approval.

For more information about pharmaceutical patents in relation to generic versions of drugs, see Generic Drugs.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki